Atrial Appendage Occluder Market is expected to garner a value of US$ 7,316.9 Million by 2032, with a CAGR of 23.95%

The Atrial Appendage Occluder Market size was worth US$ 854.6 million in 2022 and is expected to rise at a staggering double-digit CAGR of 23.95% to reach US$ 7,316.9 million by the end of the forecast year (2022 to 2032).

The left atrial appendage (LAA), also known as the atrial appendage, is an ear-shaped pouch situated in the upper left chamber of the human heart, the left atrium. Regardless of its structure, the function of LAA is unknown. Individuals with arrhythmic cardiovascular diseases, such as atrial fibrillation, may have blood accumulation in the LAA, resulting in the production of blood clots that, if they enter the bloodstream, can cause deadly strokes.

Get Full PDF Sample Copy of Latest Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-4049

To avoid such difficulties, in addition to oral anticoagulants, an occluder can be used to permanently block off the LAA. Atrial appendage occlusion, which includes inserting a plug into the appendage, is a potential approach for protecting patients’ cardiovascular health.

According to a recent study published in the journal Clinical Medical Insights: Cardiology, atrial fibrillation affects about 2% of the global population, with the disease’s incidence expected to rise fivefold over the next four decades, particularly in the United States due to its growing elderly population.

Atrial Appendage Occluder Market: Drivers and Restraints

The increased number of cardiovascular patients diagnosed with thromboembolism and atrial fibrillation worldwide is driving the global market for Atrial Appendage Occluders. Sedentary lifestyles and accompanying diseases such as diabetes, obesity, and hypertension have further increased demand for such devices, paving the way for market expansion.

However, the restricted usage of LAA occluders in patients at high risk of stroke and bleeding while on anticoagulant medication may limit market expansion. Furthermore, the implantation and removal of the device can result in complications such as tissue erosion, which may necessitate open-heart surgery, restricting market growth. Furthermore, unfavourable laws governing endocardial LAA closure have stifled industry expansion.

Contact Us for a Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-4049

Atrial Appendage Occluder Market: Overview

With only a few competitors, the global Atrial Appendage Occluder market is extremely consolidated. According to the World Health Organisation (WHO), over 15 million strokes occur worldwide each year. In 2010, the US spent around $53.9 billion on health care services, medications, and lost work days due to a heart attack.

Ischemic strokes, which occur when blood circulation to the brain is disrupted, account for approximately 87% of all strokes. Stroke is the third leading cause of death and the leading cause of long-term disability. Atrial fibrillation is responsible for around 20% of ischemic strokes.

Atrial Appendage Occluder Market: Region-wise Outlook

North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and the Middle East and Africa are the geographical segments of the Atrial Appendage Occluder Market. The North American market now leads the global industry, owing mostly to its vast elderly population.

Atrial Appendage Occluder Market: Key Players

The key players in the global Atrial Appendage Occluder Market include Appriva Medical Inc., Boston Scientific, St. Jude Medical, SentreHEART Inc, pfm medical ag., Occlutech, W. L. Gore & Associates, Inc., Cardia, Inc. and AtriCure, Inc.

Request Report Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-4049

Key Segments Profiled In The Atrial Appendage Occluder Industry Survey

Type of indication:

  • Non-valvular Atrial Fibrillation

Procedure of positioning of the device:

  • Endocardial
  • Epicardial

End user:

  • Hospitals
  • Clinics

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedInTwitterBlogs

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these